Status and progress of polypoidal choroidal vasculopathy
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

National Natural Science Foundation of China(No.81070744); Medical Technology Development Project of Nanjing, China(No.YKK12207, No.YKK12208, No.ZKX12047)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Polypoidal choroidal vasculopathy(PCV)is a disease of which the etiology and pathogenesis are still unknown, and some studies have shown that it may be related to certain genes. The funduscopic presentation of PCV is similar to that of exudative age-related macular degeneration(AMD). PCV could be distinguished from AMD through imaging such as indocyanine green angiography(ICGA)and optic coherence tomography(OCT). The diagnosis could be made if subretinal orangered lesions by ophthalmoscope and branching choroidal vessels with poly-like terminal aneurismal dilations on ICGA are seen. The treatment of PCV mainly includes photodynamic therapy(PDT), intravitreal anti-angiogenesis therapy, and combination therapy. We review the nature of PCV through its history, epidemiology, pathology, pathogenesis, gene, clinical manifestation, imaging, diagnosis and treatment. The further research direction of PCV is discussed and proposed at last.

    Reference
    Related
    Cited by
Get Citation

Xi Chen, Qin Jiang, Jin Yao. Status and progress of polypoidal choroidal vasculopathy. Guoji Yanke Zazhi( Int Eye Sci) 2013;13(3):481-484

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:November 23,2012
  • Revised:February 20,2013
  • Adopted:
  • Online:
  • Published: